Samuel J - Search Results

1

STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.

Alshamsan A, Haddadi A, Hamdy S, Samuel J, El-Kadi AO, Uludağ H, Lavasanifar A. Alshamsan A, et al. Among authors: samuel j. Mol Pharm. 2010 Oct 4;7(5):1643-54. doi: 10.1021/mp100067u. Epub 2010 Sep 14. Mol Pharm. 2010. PMID: 20804176

2

Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells.

Haddadi A, Elamanchili P, Lavasanifar A, Das S, Shapiro J, Samuel J. Haddadi A, et al. Among authors: samuel j. J Biomed Mater Res A. 2008 Mar 15;84(4):885-98. doi: 10.1002/jbm.a.31373. J Biomed Mater Res A. 2008. PMID: 17647224

3

Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.

Molavi O, Ma Z, Mahmud A, Alshamsan A, Samuel J, Lai R, Kwon GS, Lavasanifar A. Molavi O, et al. Among authors: samuel j. Int J Pharm. 2008 Jan 22;347(1-2):118-27. doi: 10.1016/j.ijpharm.2007.06.032. Epub 2007 Jun 26. Int J Pharm. 2008. PMID: 17681440 Free PMC article.

4

Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.

Hamdy S, Molavi O, Ma Z, Haddadi A, Alshamsan A, Gobti Z, Elhasi S, Samuel J, Lavasanifar A. Hamdy S, et al. Among authors: samuel j. Vaccine. 2008 Sep 15;26(39):5046-57. doi: 10.1016/j.vaccine.2008.07.035. Epub 2008 Aug 3. Vaccine. 2008. PMID: 18680779

5

Immunomodulatory and anticancer effects of intra-tumoral co-delivery of synthetic lipid A adjuvant and STAT3 inhibitor, JSI-124.

Molavi O, Ma Z, Hamdy S, Lavasanifar A, Samuel J. Molavi O, et al. Among authors: samuel j. Immunopharmacol Immunotoxicol. 2009 Jun;31(2):214-21. doi: 10.1080/08923970802380452. Immunopharmacol Immunotoxicol. 2009. PMID: 18798092

6

Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine.

Alshamsan A, Haddadi A, Incani V, Samuel J, Lavasanifar A, Uludağ H. Alshamsan A, et al. Among authors: samuel j. Mol Pharm. 2009 Jan-Feb;6(1):121-33. doi: 10.1021/mp8000815. Mol Pharm. 2009. PMID: 19053537

7

The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.

Alshamsan A, Hamdy S, Samuel J, El-Kadi AO, Lavasanifar A, Uludağ H. Alshamsan A, et al. Among authors: samuel j. Biomaterials. 2010 Feb;31(6):1420-8. doi: 10.1016/j.biomaterials.2009.11.003. Epub 2009 Nov 13. Biomaterials. 2010. PMID: 19913908

8

Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.

Molavi O, Mahmud A, Hamdy S, Hung RW, Lai R, Samuel J, Lavasanifar A. Molavi O, et al. Among authors: samuel j. Mol Pharm. 2010 Apr 5;7(2):364-74. doi: 10.1021/mp900145g. Mol Pharm. 2010. PMID: 20030320

9

Validation of bone marrow derived dendritic cells as an appropriate model to study tumor-mediated suppression of DC maturation through STAT3 hyperactivation.

Alshamsan A, Hamdy S, Das S, Lavasanifar A, Samuel J, El-Kadi AO. Alshamsan A, et al. Among authors: samuel j. J Pharm Pharm Sci. 2010 Feb 2;13(1):21-6. doi: 10.18433/j37598. J Pharm Pharm Sci. 2010. PMID: 20456827 Free article.

10

Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles.

Ghotbi Z, Haddadi A, Hamdy S, Hung RW, Samuel J, Lavasanifar A. Ghotbi Z, et al. Among authors: samuel j. J Drug Target. 2011 May;19(4):281-92. doi: 10.3109/1061186X.2010.499463. Epub 2010 Jun 30. J Drug Target. 2011. PMID: 20590403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

847 results

Search Page

Filters